Cutler Group LP Sellas Life Sciences Group, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$2.14 - $4.15 $3,424 - $6,640	-1,600 Reduced 94.12%	100 $0
Q1 2022 Apr 14, 2022	SELL	$4.73 - $7.18 $8,514 - $12,924	-1,800 Reduced 51.43%	1,700 $0
Q2 2021 Jul 19, 2021	SELL	$7.19 - $13.71 $44,578 - $85,002	-6,200 Reduced 63.92%	3,500 $2,000
Q1 2021 Apr 26, 2021	BUY	$5.5 - $11.71 $53,350 - $113,587	9,700 New	9,700 $2,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.